2005 Annual Meeting | Clinical Grant Writing

Date Tuesday 04/12/05

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Karl D. Kieburtz, MD

Topic(s) Research/Education

Learning Objectives Upon completion:
Participants should know the basics of writing an NIH grant; the components of a clinical trial grant application; and the NIH grant review process.

CME Available No CME available

Program Level Introductory

Recommended Audience Fellow, Resident

Event Timeline
06:45 AM - 08:15 AM		Clinical Grant Writing Karl D. Kieburtz, MD, Bernard M. Ravina, MD, MSCE
06:45 AM - 08:30 AM		Breakfast
08:15 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Bernard M. Ravina, MD, MSCE	Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.